Navigation Links
GlaxoSmithKline and AFFiRiS Sign an Exclusive Licence and Option Agreement for Therapeutic Alzheimer's Disease Candidate Vaccines
Date:10/23/2008

VIENNA, Austria, October 23 /PRNewswire/ -- GlaxoSmithKline Biologicals S.A. (GSK) and AFFiRiS GmbH announced today the execution of a collaboration agreement granting GSK exclusive rights to AFFiRiS's Alzheimer's disease vaccine programmes, aimed at treating Alzheimer's by targeting beta-amyloid.

As part of the agreement GSK is acquiring exclusive rights to develop and commercialise two Alzheimer's disease vaccine candidates that are based on AFFiRiS AFFiTOPE technology and are currently in Phase I clinical development. AFFiRiS is also granting GSK an exclusive option to develop and commercialise alternative Alzheimer's disease vaccine candidates which are in preclinical development.

Under the terms of the agreement, AFFiRiS will receive an up-front payment of EUR 22.5 million (GBP17.5 million) and could be eligible for future milestone payments and royalties. The total potential value of the agreement could reach EUR 430 million (GBP334 million) in the event of full commercial success of the candidate vaccines. This agreement is subject to governmental authority approval.

Central to the deal is the AFFiRiS AFFiTOPE technology which allows the design of proteins with very specific binding characteristics that are ideally suited for the development of vaccines against disease-causing "rogue" human proteins such as beta-amyloid which is central to the pathology of Alzheimer's disease.

Commenting on the agreement, Walter Schmidt, co-founder and CEO of AFFiRiS, stated: "We are pleased that we could secure GSK Biologicals, one of the world's leading vaccine companies, in collaborating on the development our Alzheimer's disease vaccine programs. This deal brings together two companies with strong innovation, vaccine development and commercialisation capabilities and experience."

Jean Stephenne, President and General Manager of GlaxoSmithKline Biologicals, said "We are impressed with the AFFiRiS technology - combined with our expe
'/>"/>

SOURCE AFFiRiS GmbH, GlaxoSmithKline Biologicals (GSKBiologicals)
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. GlaxoSmithKline and Cellzome Announce Major Strategic Alliance
2. GlaxoSmithKline Offers New Purchasing Options to Help Employers Overcome Barriers to Pandemic Stockpiling of Relenza(R)
3. GlaxoSmithKline To Post Quarterly US Grants Report
4. GlaxoSmithKline - Q2 Results and Strategy Update - Interview with CEO
5. Exelixis and GlaxoSmithKline Agree to Successfully Conclude Six-Year Discovery and Development Collaboration
6. CDC Immunization Advisory Committee Recommends Two New Pediatric Vaccines from GlaxoSmithKline
7. FDA Approves GlaxoSmithKlines AVODART(R) in Combination with Tamsulosin for the Treatment of Symptomatic Enlarged Prostate
8. GlaxoSmithKline and Mpex Pharmaceuticals Form Alliance to Develop Novel Efflux Pump Inhibitors for Use Against Serious Gram-Negative Infections
9. GlaxoSmithKline Signs Licensing Agreement With Compendia Bioscience
10. GlaxoSmithKline Named A Top Employer for Promoting Healthy Lifestyles
11. GlaxoSmithKline Commences Tender Offer to Acquire Sirtris Pharmaceuticals

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)...NTON, Mass., Dec. 3 Cali...g provider of tools and services for drug discover...ing Image 4.0 software for IVIS® in vivo imag... than 800 Caliper IVIS systems currently installed...res advanced spectral unmixing tools to enhance fl...
(Date:12/2/2009)...BIA, Md., Dec. 2 Martek ... today that it intends to release the results of i... 16, 2009, at approximately 4:00 p.m. Eastern Time...tek will conduct a conference call to discuss thes...may listen to the call live via webcast by visitin...
(Date:12/2/2009)...EW YORK, Dec. 2 Reportlinker.com a...lable in its catalogue: ,, Neurostimulation - ...ortlinker.com/p0164232/Neurostimulation---A-Global...imulation market stands enthused by the growing ba...age-related diseases such as, Parkinson,s, and Alz...
(Date:12/2/2009)...EW YORK, Dec. 2 Reportlinker.com a...lable in its catalogue: ,, Drug Discovery Tech...Opportunities ,, http://www.reportlinker.com/...date-of-Market-Trends--Opportunities.html ,, D...lement of every pharmaceutical company,s business ...
Breaking Biology Technology:Caliper Life Sciences Launches Living Image(R) 4.0 Software 2Martek to Announce Fourth Quarter and Fiscal Year 2009 Results 2Reportlinker Adds Neurostimulation - A Global Market Perspective 2Reportlinker Adds Neurostimulation - A Global Market Perspective 3Reportlinker Adds Neurostimulation - A Global Market Perspective 4Reportlinker Adds Neurostimulation - A Global Market Perspective 5Reportlinker Adds Neurostimulation - A Global Market Perspective 6Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 2Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 3Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 4Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 5Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 6Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 7Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 8Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 9
...corporated,(Nasdaq: GPRO ) announced today that t...Annual Investment Conference in San Francisco on S...ic Time (5:30 p.m. Eastern Time).,The presentation...ed,through a link on the investor information sect...e.com . The webcast will be available for 30 days,...
..., Inc. (OTC,Bulletin Board: SYMD.OB), today announ...perative Adhesions in Cardiac Surgery: Challenges ...European Association for,Cardio- Thoracic Surgery ...um will be chaired by Professor Stephen Westaby of...gdom and will include presentations,by principal i...
...,Technologies, Inc. (Amex: PTN ) stated today tha...y Competitive Technologies, Inc. (Amex: CTT ),rel...cense agreement was,false and misleading. The pre...Technologies,Terminates License Agreement with Pal...tion sent by CTT to Palatin the day before express...
Other Biology Technology:Gen-Probe to Webcast Presentation at Bank of America's 37th Annual Investment Conference 2SyntheMed to Host Symposium on Adhesions in Cardiac Surgery 2Palatin Technologies Refutes Competitive Technologies Contention of Material Breach 2
(Date:12/3/2009)...llers must be included in the design of the upcomi...umanitarian crisis, according to a scientist at th...re , Dr Simon Lewis argues that at least 50% of th...n, known as REDD (Reducing Emissions from Deforest...wellers directly, and their property rights assure...
(Date:12/3/2009)... A team of scientists from the U.S. Department of ...vard University, and the Indian Institute of Scien...cules locate the genetic information in DNA that i...esses. The research, published in the December 1, ...logy , confirms that many proteins responsible for...
(Date:12/2/2009)...ELPHIA Less acculturated Latino men have a more d...more acculturated to U.S. culture, but acculturati...ng. Details of these findings are published in Ca...rnal of the American Association for Cancer Resear...cco. , "Acculturation affects smoking cessation ...
Breaking Biology News(10 mins):Forest deal at Copenhagen must avoid creating 'carbon refugees' 2Grooving down the helix 2Grooving down the helix 3Acculturation affects smoking cessation success among Latinos 2Section 1803 3A Senate Health Care Bill Makes Planned Parenthood Quasi Government Agency 3F Asks ALL 60180 1Section 1803 3A Senate Health Care Bill Makes Planned Parenthood Quasi Government Agency 3F Asks ALL 60180 21 800 Therapist Announces New Executive Team and Tele Therapy Offering 60177 11 800 Therapist Announces New Executive Team and Tele Therapy Offering 60177 2IRSF Receives 1 Million Dollar Matching Gift 60174 1IRSF Receives 1 Million Dollar Matching Gift 60174 2IRSF Receives 1 Million Dollar Matching Gift 60174 3IRSF Receives 1 Million Dollar Matching Gift 60174 4
...vy smoking may reduce female fertility by directly...d reducing the chances the embryo will implant, ac...November) in Europe,s leading reproductive medicin... a team of fertility experts in Portugal and Spain...es between non-heavy smokers and heavy smokers, al...
...ormation on the global burden of malaria remains t...urce allocation for malaria control remains "drive...ctive assessment of need," say two prominent malar...obert Snow (Kenya Medical Research Institute and U...40 years since the last global map of malaria ende...
...d seeps are deep-sea environments, usually a few s...ugh slow diffusion from the sea floor. Mud volcano...her extreme environments discovered in the 1990s. ...st extreme and scientifically challenging environm... fields of hydrocarbon-rich gas seepage, mud volca...
Other Biology News:Heavy smoking cuts women's chance of pregnancy -- even with donated oocytes 2Heavy smoking cuts women's chance of pregnancy -- even with donated oocytes 3Life in the extreme 2
Beagle Serum from Innovative Research
Mouse Anti-Human MBP aa67-74 Monoclonal Antibody, Unconjugated from AbD Serotec
Mouse Anti-Bovine TROPONIN I (CARDIAC & SKELETAL) Monoclonal Antibody, Unconjugated, Clone C5 from AbD Serotec
X-Gal/IPTG Solution from Bioline
Biology Products: